CVE-2021-43094An SQL Injection vulnerability exists in OpenMRS Reference Application Standalone Edition <=2.11 and Platform Standalone Edition <=2.4.0 via GET requests on arbitrary parameters in patient.page.
Updated under an hour ago ()
Does this affect you?
It affects openmrs and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 1.28%, higher than 70% of scored CVEs.
Do this next
Free account, 1 product
An SQL Injection vulnerability exists in OpenMRS Reference Application Standalone Edition <=2.11 and Platform Standalone Edition <=2.4.0 via GET requests on arbitrary parameters in patient.page.
- CVSS
- 9.8 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 1.28% (percentile 70)
- Assigned by
- mitre
- NVD analysis
- Modified
- Record last updated
- Aug 4, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
openmrs openmrs openmrs:openmrs | through 2.4.0 | NVD |
openmrs reference_application openmrs:reference_application | through 2.11 | NVD |
References
- https://wiki.openmrs.org/display/docs/Reporting+Bugsx-refsource-misc, vendor-advisory
- https://openmrs.org/demo/x-refsource-misc, product
- https://issues.openmrs.org/browse/TRUNK-6043x-refsource-misc, issue-tracking, third-party-advisory, vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.